6533b82ffe1ef96bd129618e

RESEARCH PRODUCT

“OXXEL (Oxaliplatin plus Xeloda) versus OXAFAFU (Oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis”

Sandomenico CFilippelli GMassidda BPutzu CNatale DMaiorino LCondemi GLeo SGambardella A. Comella P.Sergio Palmeri

subject

http://hdl.handle.net/10447/12172